MiniMed is a scaled global medical technology company that develops, manufactures, and markets a comprehensive suite of solutions for the management of diabetes.

Since our founding more than 40 years ago, we have pioneered groundbreaking innovation and served the needs of our customers across the globe in service of our mission to make every day a better day for people with diabetes. Today, we are the only player in the market that commercializes all parts of an integrated diabetes management system.

We are committed to delivering long-term, meaningful value to shareholders given our diversified business with leading market positions in growth markets, and a robust product pipeline.

• 8K+

  Global employees

• 80+

  Countries served

• 659K+

  Customers globally

Featured Presentation

June 2026